Mirati Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Mirati Therapeutics has a total shareholder equity of $946.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.1B and $183.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$978.52m |
| Equity | US$946.47m |
| Total liabilities | US$183.24m |
| Total assets | US$1.13b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: M2RT34's short term assets ($1.0B) exceed its short term liabilities ($137.4M).
Long Term Liabilities: M2RT34's short term assets ($1.0B) exceed its long term liabilities ($45.9M).
Debt to Equity History and Analysis
Debt Level: M2RT34 is debt free.
Reducing Debt: M2RT34 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: M2RT34 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if M2RT34 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.